This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: The Innovations of Jonas Rickard Fägerhag
Introduction
Jonas Rickard Fägerhag is a notable inventor based in Mölndal, Sweden. He has made significant contributions to the field of therapeutic agents, particularly in the treatment and prevention of diseases mediated through glucokinase. His work has implications for improving insulin secretion and managing glucose levels in patients.
Latest Patents
Fägerhag holds a patent for a compound of Formula (I), which is recognized for its utility in treating or preventing medical conditions associated with glucokinase. This innovation is crucial for developing new therapeutic strategies for diabetes and related metabolic disorders.
Career Highlights
Fägerhag is associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca has allowed him to engage in cutting-edge research and development, contributing to advancements in medical science and patient care.
Collaborations
Throughout his career, Fägerhag has collaborated with esteemed colleagues, including Stuart Norman Lile Bennett and Roger John Butlin. These partnerships have fostered a collaborative environment that enhances innovation and the development of new therapeutic solutions.
Conclusion
Jonas Rickard Fägerhag's contributions to the field of therapeutic agents exemplify the impact of innovative thinking in medicine. His work continues to influence the development of treatments that improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile